Funding Rounds
Oculis Series C (2021, $57M)
OculisPharmaceutical company focusing on developing and delivering eye-related drugs.
Summary
Stage: Series C
Raised Amount: $57.00M
Raised Date: 2021-01-01
Stage: Series C
Raised Amount: $57.00M
Raised Date: 2021-01-01